Comparative Analysis of Surgical Intervention and Stereotactic Body Radiotherapy in Oligometastatic Colorectal Cancer: A Prospective Cohort Study Utilizing Propensity Score Matching - Top-Institutions - MDSpire

Comparative Analysis of Surgical Intervention and Stereotactic Body Radiotherapy in Oligometastatic Colorectal Cancer: A Prospective Cohort Study Utilizing Propensity Score Matching

  • By

  • Daohai Wang

  • Zhili Zhao

  • Weijie Zhao

  • Guanglong Chen

  • Wei Du

  • Zhi Li

  • Jian Zhang

  • December 22, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Surgical Oncology
    • Radiation Oncology
    • Medical Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Radiation Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Surgical Oncology

  • #4

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Surgical Oncology
    • Radiation Oncology

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Surgical Oncology
    • Radiation Oncology

Original Source(s)

Comparative Analysis of Surgical Intervention and Stereotactic Body Radiotherapy in Oligometastatic Colorectal Cancer: A Prospective Cohort Study Utilizing Propensity Score Matching

  • by Daohai Wang, Zhili Zhao, Weijie Zhao, Guanglong Chen, Wei Du, Zhi Li, Jian Zhang

  • December 22, 2025

Related Content

First case report of hypouricemia associated with adjuvant imatinib therapy in a patient with small intestinal gastrointestinal stromal tumor

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Hyperthermia enhances the efficacy of PD-1 inhibitor plus chemotherapy in PD-L1 CPS-negative advanced gastric cancer